Teplizumab trials for Type 2 diabetes

All Teplizumab trials · All Type 2 diabetes trials

Phase breakdown

Recruiting trials studying Teplizumab for Type 2 diabetes

• A Longitudinal, Observational Study Comparing Real-World Experiences of Teplizumab-Treated and Untreated Participants With Stage 2 Type 1 Diabetes in the United States
  NCT07260110 · Phase: Not specified · Ages: 8 Years and older · Sex: All (male and female) · 1 location
• Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
  NCT06791291 · Phase: Phase 2 · Ages: 1 Year to 34 Years · Sex: All (male and female) · 11 locations
• Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
  NCT07216391 · Phase: Phase 2 · Ages: 4 Years to 34 Years · Sex: All (male and female) · 6 locations
• Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
  NCT07457580 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 14 locations

Common questions

How many trials study Teplizumab for Type 2 diabetes?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.